{"id":79713,"date":"2026-01-02T23:13:05","date_gmt":"2026-01-02T14:13:05","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/rare-neurological-disease-treatment-market-mordor\/"},"modified":"2026-03-27T16:31:35","modified_gmt":"2026-03-27T07:31:35","slug":"rare-neurological-disease-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/rare-neurological-disease-treatment-market-mordor\/","title":{"rendered":"\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834 \u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u30c8\u30ec\u30f3\u30c9\u30fb\u4e88\u6e2c (2025\u5e74 &#8211; 2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/rare-neurological-disease-treatment-market_1646310519086_logo_rare-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/rare-neurological-disease-treatment-market-size-image-1753872789583.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0 &amp; \u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u306e\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u6982\u89b3<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 FDA\u306e\u8fc5\u901f\u5be9\u67fb\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u306b\u3088\u308b\u7814\u7a76\u958b\u767a\u6295\u8cc7\u306e\u4fc3\u9032<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u8a3a\u65ad\u306e\u6539\u5584\u306b\u3088\u308b\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306e\u6709\u75c5\u7387\u306e\u4e0a\u6607<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u5e0c\u5c11CNS\u75be\u60a3\u3092\u6a19\u7684\u3068\u3059\u308b\u907a\u4f1d\u5b50\u30fbRNA\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\u8cc7\u91d1\u306e\u6025\u5897<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u306a\u3069\u306e\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 AI\u3092\u6d3b\u7528\u3057\u305f\u85ac\u5264\u518d\u5229\u7528\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3088\u308bCNS\u5e0c\u5c11\u75be\u60a3\u9069\u5fdc\u75c7\u306e\u7279\u5b9a<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 \u56fd\u5883\u3092\u8d8a\u3048\u305f\u60a3\u8005\u652f\u63f4\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0\u306b\u3088\u308b\u4eba\u9053\u7684\u898b\u5730\u304b\u3089\u306e\u4f7f\u7528\u30a2\u30af\u30bb\u30b9\u306e\u52a0\u901f<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u751f\u7269\u88fd\u5264\u304a\u3088\u3073\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u9ad8\u30b3\u30b9\u30c8\u304c\u624b\u9803\u306a\u4fa1\u683c\u3092\u5236\u9650<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u6975\u3081\u3066\u5c11\u306a\u3044\u60a3\u8005\u30d7\u30fc\u30eb\u306b\u3088\u308b\u81e8\u5e8a\u8a66\u9a13\u306e\u88ab\u9a13\u8005\u52df\u96c6\u306e\u8ab2\u984c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 \u53b3\u683c\u306aCNS\u5b89\u5168\u6027\u8981\u4ef6\u304c\u898f\u5236\u627f\u8a8d\u671f\u9593\u3092\u9577\u671f\u5316<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \u65b0\u8208\u5e02\u5834\u306b\u304a\u3051\u308b\u9ac4\u8154\u5185RNA\u533b\u85ac\u54c1\u306e\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u7269\u6d41\u306e\u30ae\u30e3\u30c3\u30d7<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30d0\u30ea\u30e5\u30fc\/\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u5206\u6790<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \u898f\u5236\u74b0\u5883<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.6 \u6280\u8853\u7684\u5c55\u671b<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.7 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.7.1 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.2 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.3 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.7.5 \u7af6\u4e89\u306e\u5ea6\u5408\u3044<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u6cbb\u7642\u30bf\u30a4\u30d7\u5225\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u4f4e\u5206\u5b50\u533b\u85ac\u54c1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u30d0\u30a4\u30aa\u533b\u85ac\u54c1 &amp; \u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u907a\u4f1d\u5b50\u6cbb\u7642<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u9175\u7d20\u88dc\u5145\u7642\u6cd5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 RNA\u30d9\u30fc\u30b9\u6cbb\u7642<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.6 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u9069\u5fdc\u75c7\u5225\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u30c7\u30e5\u30b7\u30a7\u30f3\u30cc\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u30d0\u30c3\u30c6\u30f3\u75c5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.4 \u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\uff08\u5e0c\u5c11\u578b\uff09<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.5 \u30cf\u30f3\u30c1\u30f3\u30c8\u30f3\u75c5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.6 \u5e0c\u5c11\u3066\u3093\u304b\u3093\u75c7\u5019\u7fa4<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.7 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u6295\u4e0e\u7d4c\u8def\u5225\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u7d4c\u53e3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u9759\u8108\u5185<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u305d\u306e\u4ed6<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u5730\u57df\u5225\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.2 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.3 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.4 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.5 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb {(\u30b0\u30ed\u30fc\u30d0\u30eb\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u7684\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30e9\u30f3\u30af\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1&amp;\u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080)}<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 Biogen Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 Roche Holding AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 Pfizer Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 Sarepta Therapeutics, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 Ionis Pharmaceuticals, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 UCB S.A.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 Argenx SE<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 Reata Pharmaceuticals, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 Sanofi S.A.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 AstraZeneca PLC<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 BioMarin Pharmaceutical Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 Jazz Pharmaceuticals plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 Ultragenyx Pharmaceutical Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 PTC Therapeutics, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 CSL Limited<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 Ipsen S.A.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 Mitsubishi Tanabe Pharma Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 Marinus Pharmaceuticals, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 Catalyst Pharmaceuticals, Inc.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a&amp;\u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306e\u6982\u8981<\/p>\n<p>\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f157.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012030\u5e74\u307e\u3067\u306b217.9\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f6.75%\u3067\u3059\u3002\u3053\u306e\u6210\u9577\u306f\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u627f\u8a8d\u5897\u52a0\u3001\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u6307\u5b9a\u306e\u8fc5\u901f\u5316\u3001\u8d85\u5e0c\u5c11\u4e2d\u67a2\u795e\u7d4c\u7cfb\uff08CNS\uff09\u30d7\u30ed\u30b0\u30e9\u30e0\u3078\u306e\u30d9\u30f3\u30c1\u30e3\u30fc\u8cc7\u91d1\u306e\u6d41\u5165\u304c\u4e3b\u306a\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002RNA\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u6210\u719f\u3068\u3001\u7c73\u56fd\u304a\u3088\u3073EU\u306b\u304a\u3051\u308b\u898f\u5236\u7d4c\u8def\u306e\u5408\u7406\u5316\u306b\u3088\u308a\u3001\u5e73\u5747\u627f\u8a8d\u671f\u9593\u304c18\u30f6\u6708\u77ed\u7e2e\u3055\u308c\u3001\u5546\u696d\u5316\u306e\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u304c\u3055\u3089\u306b\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002\u6295\u8cc7\u5bb6\u306f\u3001\u691c\u8a3c\u6e08\u307f\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u6280\u8853\u306b\u9ad8\u3044\u8a55\u4fa1\u3092\u4e0e\u3048\u7d9a\u3051\u3066\u304a\u308a\u3001\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u3068\u5c02\u9580\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u9593\u306e\u7d71\u5408\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u306b\u306f\u3001\u5317\u7c73\u304c\u5145\u5b9f\u3057\u305f\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3068\u4fdd\u967a\u9069\u7528\u306b\u3088\u308a\u63a1\u7528\u3092\u4e3b\u5c0e\u3057\u3066\u304a\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u5404\u56fd\u653f\u5e9c\u304c\u5e0c\u5c11\u75be\u60a3\u5bfe\u7b56\u3092\u56fd\u5bb6\u533b\u7642\u6226\u7565\u306b\u7d44\u307f\u8fbc\u3080\u3053\u3068\u3067\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u8a18\u9332\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001\u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u3001\u53b3\u683c\u306a\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u8981\u4ef6\u3001\u305d\u3057\u3066\u8d85\u5c11\u6570\u306e\u60a3\u8005\u30b3\u30db\u30fc\u30c8\u3092\u52df\u96c6\u3059\u308b\u3068\u3044\u3046\u8ab2\u984c\u304c\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u30dd\u30a4\u30f3\u30c8<\/p>\n<p>*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225: \u907a\u4f1d\u5b50\u6cbb\u7642\u304c2024\u5e74\u306b36.32%\u3068\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u307e\u3057\u305f\u3002RNA\u30d9\u30fc\u30b9\u6cbb\u7642\u306f2030\u5e74\u307e\u3067\u306b7.24%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306a\u62e1\u5927\u3092\u898b\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9069\u5fdc\u75c7\u5225: \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\uff08SMA\uff09\u304c2024\u5e74\u306b\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u5e02\u5834\u898f\u6a21\u306e28.70%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u30c7\u30e5\u30b7\u30a7\u30f3\u30cc\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\uff08DMD\uff09\u306f8.01%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3057\u3066\u3044\u308b\u9069\u5fdc\u75c7\u3067\u3059\u3002<br \/>\n*   \u6295\u4e0e\u7d4c\u8def\u5225: \u9759\u8108\u5185\u6295\u4e0e\u304c2024\u5e74\u306b44.12%\u3068\u5e02\u5834\u3092\u30ea\u30fc\u30c9\u3057\u307e\u3057\u305f\u3002\u9ac4\u8154\u5185\u3001\u76ae\u4e0b\u3001\u305d\u306e\u4ed6\u306e\u65b0\u8208\u6295\u4e0e\u65b9\u6cd5\u306f\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306b8.56%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5730\u57df\u5225: \u5317\u7c73\u304c2024\u5e74\u306b\u53ce\u76ca\u306742.23%\u3092\u5360\u3081\u3001\u5730\u7406\u7684\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u652f\u914d\u3057\u307e\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f2030\u5e74\u307e\u3067\u306b9.72%\u306eCAGR\u3067\u6700\u3082\u9ad8\u3044\u6210\u9577\u7387\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u52d5\u5411\u3068\u6d1e\u5bdf<\/p>\n<p>\u4fc3\u9032\u8981\u56e0<\/p>\n<p>*   FDA\u306e\u8fc5\u901f\u5be9\u67fb\u304a\u3088\u3073\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u512a\u9047\u63aa\u7f6e\u306b\u3088\u308b\u7814\u7a76\u958b\u767a\u6295\u8cc7\u306e\u4fc3\u9032: FDA\u306e\u5e0c\u5c11\u75be\u60a3\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30cf\u30d6\u306f\u3001\u5c02\u9580\u306e\u5be9\u67fb\u5b98\u3092\u914d\u7f6e\u3057\u3001\u6a19\u6e96\u7684\u306a\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u3092\u77ed\u7e2e\u3059\u308b\u512a\u5148\u30b5\u30a4\u30af\u30eb\u3067\u7533\u8acb\u66f8\u985e\u3092\u51e6\u7406\u3057\u3066\u3044\u307e\u3059\u30022024\u5e74\u4ee5\u964d\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u6307\u5b9a\u306f\u524d\u5e74\u6bd434%\u5897\u52a0\u3057\u3001\u30cf\u30f3\u30c1\u30f3\u30c8\u30f3\u75c5\u306b\u5bfe\u3059\u308bUniQure\u306eAMT-130\u3084PTC Therapeutics\u306ePTC518\u306a\u3069\u306e\u627f\u8a8d\u304c\u5148\u4f8b\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u30027\u5e74\u9593\u306e\u5e02\u5834\u72ec\u5360\u6a29\u3001\u624b\u6570\u6599\u514d\u9664\u3001\u7a0e\u984d\u63a7\u9664\u306b\u3088\u308a\u3001\u30cb\u30c3\u30c1\u306a\u9069\u5fdc\u75c7\u3067\u3042\u3063\u3066\u3082\u7d4c\u6e08\u7684\u306b\u9b45\u529b\u7684\u3067\u3042\u308a\u3001\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u304c\u304b\u3064\u3066\u652f\u914d\u3057\u3066\u3044\u305f\u5206\u91ce\u306b\u4e2d\u5c0f\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3092\u8a98\u81f4\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u8a3a\u65ad\u6280\u8853\u306e\u5411\u4e0a\u306b\u3088\u308b\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306e\u6709\u75c5\u7387\u4e0a\u6607: \u7c73\u56fd\u5168\u5dde\u3067\u306e\u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u306e\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u666e\u53ca\u306b\u3088\u308a\u3001\u75c7\u72b6\u767a\u73fe\u524d\u306b\u7f79\u60a3\u4e73\u5150\u3092\u7279\u5b9a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u65e9\u671f\u306e\u30be\u30eb\u30b2\u30f3\u30b9\u30de\u3084\u30b9\u30d4\u30f3\u30e9\u30b6\u6295\u4e0e\u306b\u3088\u308b\u751f\u6daf\u306b\u308f\u305f\u308b\u8ee2\u5e30\u304c\u6539\u5584\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5168\u30b2\u30ce\u30e0\u30b7\u30fc\u30b1\u30f3\u30b7\u30f3\u30b0\u306e\u30b3\u30b9\u30c8\u306f2001\u5e74\u4ee5\u964d99.9%\u6025\u843d\u3057\u3001\u9ad8\u5ea6\u306a\u8a3a\u65ad\u304c\u5730\u57df\u75c5\u9662\u3067\u3082\u5229\u7528\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002<br \/>\n*   \u907a\u4f1d\u5b50\u6cbb\u7642\u304a\u3088\u3073RNA\u6cbb\u7642\u3078\u306e\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\u8cc7\u91d1\u306e\u6025\u5897: \u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u306f\u30012024\u5e74\u306b28\u5104\u7c73\u30c9\u30eb\u3092\u8abf\u9054\u3057\u3001\u696d\u754c\u5168\u4f53\u306e\u8cc7\u91d1\u8abf\u9054\u304c\u53b3\u3057\u304f\u306a\u308b\u4e2d\u3067\u3082\u524d\u5e74\u6bd423%\u5897\u52a0\u3057\u307e\u3057\u305f\u3002\u6295\u8cc7\u5bb6\u306f\u3001\u518d\u5229\u7528\u53ef\u80fd\u306a\u30c7\u30ea\u30d0\u30ea\u30fc\u30b7\u30b9\u30c6\u30e0\u3068\u30aa\u30fc\u30d5\u30a1\u30f3\u30d5\u30ec\u30fc\u30e0\u30ef\u30fc\u30af\u4e0b\u3067\u306e\u9ad8\u3044\u898f\u5236\u6210\u529f\u7387\u3092\u30ea\u30b9\u30af\u8efd\u6e1b\u8981\u56e0\u3068\u3057\u3066\u6319\u3052\u3066\u3044\u307e\u3059\u3002<br \/>\n*   SMA\u306a\u3069\u306e\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5897\u52a0: \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u306e\u666e\u904d\u7684\u306a\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306f\u3001\u30be\u30eb\u30b2\u30f3\u30b9\u30de\u3084\u30b9\u30d4\u30f3\u30e9\u30b6\u306e\u3088\u3046\u306a\u75be\u60a3\u4fee\u98fe\u7642\u6cd5\u306b\u3088\u308b\u75c7\u72b6\u767a\u73fe\u524d\u306e\u4ecb\u5165\u3092\u53ef\u80fd\u306b\u3059\u308b\u3053\u3068\u3067\u3001\u6cbb\u7642\u6210\u679c\u3092\u5909\u9769\u3057\u307e\u3057\u305f\u3002SMA\u4ee5\u5916\u306e\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306b\u3082\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\u304c\u62e1\u5927\u3059\u308b\u3053\u3068\u3067\u3001\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u6069\u6075\u3092\u53d7\u3051\u308b\u65e9\u671f\u8a3a\u65ad\u60a3\u8005\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u304c\u751f\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6291\u5236\u8981\u56e0<\/p>\n<p>*   \u751f\u7269\u88fd\u5264\u304a\u3088\u3073\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u9ad8\u30b3\u30b9\u30c8\u306b\u3088\u308b\u624b\u9803\u306a\u4fa1\u683c\u306e\u5236\u9650: \u5e0c\u5c11\u75be\u60a3\u6cbb\u7642\u306e\u5e74\u9593\u5e73\u5747\u8cbb\u7528\u306f2024\u5e74\u306b32,000\u7c73\u30c9\u30eb\u306b\u9054\u3057\u3001\u30be\u30eb\u30b2\u30f3\u30b9\u30de\u306e\u3088\u3046\u306a\u9ad8\u984d\u306a\u907a\u4f1d\u5b50\u6cbb\u7642\u306f210\u4e07\u7c73\u30c9\u30eb\u3067\u8ca9\u58f2\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u652f\u6255\u8005\u306f\u3001\u4e8b\u524d\u627f\u8a8d\u3001\u6210\u679c\u30d9\u30fc\u30b9\u306e\u5951\u7d04\u3001\u5206\u5272\u6255\u3044\u5951\u7d04\u306a\u3069\u3067\u5bfe\u5fdc\u3057\u3001\u666e\u53ca\u3092\u9045\u3089\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u8d85\u5c11\u6570\u306e\u60a3\u8005\u30d7\u30fc\u30eb\u306b\u3088\u308b\u81e8\u5e8a\u8a66\u9a13\u306e\u88ab\u9a13\u8005\u52df\u96c6\u306e\u8ab2\u984c: \u3044\u304f\u3064\u304b\u306e\u8d85\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306f\u4e16\u754c\u4e2d\u30671,000\u4eba\u672a\u6e80\u306e\u60a3\u8005\u3057\u304b\u304a\u3089\u305a\u3001\u9069\u5fdc\u578bN-of-1\u8a66\u9a13\u3084\u30d0\u30b9\u30b1\u30c3\u30c8\u8a66\u9a13\u306e\u3088\u3046\u306a\u9769\u65b0\u7684\u306a\u30c7\u30b6\u30a4\u30f3\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u306a\u5206\u6563\u306f\u7269\u6d41\u30b3\u30b9\u30c8\u3092\u5897\u52a0\u3055\u305b\u3001\u5c02\u9580\u77e5\u8b58\u306f\u5c11\u6570\u306e\u5b66\u8853\u30bb\u30f3\u30bf\u30fc\u306b\u96c6\u4e2d\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u53b3\u683c\u306aCNS\u5b89\u5168\u6027\u8981\u4ef6\u306b\u3088\u308b\u898f\u5236\u627f\u8a8d\u671f\u9593\u306e\u9577\u671f\u5316: \u4e2d\u67a2\u795e\u7d4c\u7cfb\uff08CNS\uff09\u306b\u5bfe\u3059\u308b\u53b3\u683c\u306a\u5b89\u5168\u6027\u8981\u4ef6\u306f\u3001\u65b0\u85ac\u306e\u898f\u5236\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u3092\u9577\u671f\u5316\u3055\u305b\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u65b0\u8208\u5e02\u5834\u306b\u304a\u3051\u308b\u9ac4\u8154\u5185RNA\u533b\u85ac\u54c1\u306e\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u7269\u6d41\u306e\u30ae\u30e3\u30c3\u30d7: \u65b0\u8208\u5e02\u5834\u3001\u7279\u306b\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\u3067\u306f\u3001\u9ac4\u8154\u5185RNA\u533b\u85ac\u54c1\u306e\u8f38\u9001\u30fb\u4fdd\u7ba1\u306b\u5fc5\u8981\u306a\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u7269\u6d41\u306e\u30a4\u30f3\u30d5\u30e9\u304c\u4e0d\u8db3\u3057\u3066\u304a\u308a\u3001\u5e02\u5834\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u5236\u9650\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790<\/p>\n<p>*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225: \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u30ea\u30fc\u30c9\u3092\u7dad\u6301\u3057\u3001RNA\u6cbb\u7642\u304c\u6025\u5897<br \/>\n    \u907a\u4f1d\u5b50\u6cbb\u7642\u306f\u3001\u30d6\u30ed\u30c3\u30af\u30d0\u30b9\u30bf\u30fc\u88fd\u54c1\u306e\u767a\u58f2\u3068AAV\u30d9\u30fc\u30b9\u306e\u88fd\u5264\u306e\u9069\u5fdc\u62e1\u5927\u306b\u3088\u308a\u30012024\u5e74\u306e\u53ce\u76ca\u306e36.32%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u5e02\u5834\u306b\u304a\u3051\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u898f\u6a21\u306f\u3001\u6b21\u4e16\u4ee3\u30d9\u30af\u30bf\u30fc\u304c\u3088\u308a\u5927\u304d\u306a\u907a\u4f1d\u5b50\u3084\u518d\u6295\u4e0e\u306e\u8ab2\u984c\u306b\u53d6\u308a\u7d44\u3080\u306b\u3064\u308c\u3066\u30012030\u5e74\u307e\u3067\u306b\u5e74\u95936.2%\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002RNA\u30d9\u30fc\u30b9\u6cbb\u7642\u306f\u3001\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u304a\u3088\u3073siRNA\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u9069\u5fdc\u75c7\u9593\u3067\u5316\u5b66\u3092\u518d\u5229\u7528\u3067\u304d\u308b\u3068\u3044\u3046\u6295\u8cc7\u5bb6\u306e\u95a2\u5fc3\u3092\u53cd\u6620\u3057\u30017.24%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u8a18\u9332\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9069\u5fdc\u75c7\u5225: SMA\u306e\u512a\u4f4d\u6027\u306bDMD\u304c\u8feb\u308b<br \/>\n    \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\uff08SMA\uff09\u306f\u3001\u666e\u904d\u7684\u306a\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30013\u3064\u306e\u5546\u696d\u7684\u306b\u6210\u719f\u3057\u305f\u6cbb\u7642\u6cd5\u3001\u304a\u3088\u3073\u6e2c\u5b9a\u53ef\u80fd\u306a\u81e8\u5e8a\u8ee2\u5e30\u306b\u3088\u308a\u30012024\u5e74\u306e\u58f2\u4e0a\u9ad8\u306e28.70%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u30c7\u30e5\u30b7\u30a7\u30f3\u30cc\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\uff08DMD\uff09\u306f\u3001\u30a8\u30af\u30bd\u30f3\u30b9\u30ad\u30c3\u30d4\u30f3\u30b0\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u3001\u30de\u30a4\u30af\u30ed\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30f3\u88fd\u5264\u304c\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a13\u306b\u5165\u308b\u306b\u3064\u308c\u3066\u30012030\u5e74\u307e\u3067\u306b8.01%\u306eCAGR\u3067\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6295\u4e0e\u7d4c\u8def\u5225: \u9759\u8108\u5185\u6295\u4e0e\u304c\u652f\u914d\u7684\u3060\u304c\u3001\u60a3\u8005\u306b\u512a\u3057\u3044\u5f62\u5f0f\u304c\u5897\u52a0<br \/>\n    \u9759\u8108\u5185\u6295\u4e0e\u306f\u3001\u307b\u3068\u3093\u3069\u306eAAV\u30d9\u30af\u30bf\u30fc\u304a\u3088\u3073\u7d44\u63db\u3048\u751f\u7269\u88fd\u5264\u304c\u7ba1\u7406\u3055\u308c\u305f\u75c5\u9662\u74b0\u5883\u3092\u5fc5\u8981\u3068\u3059\u308b\u305f\u3081\u30012024\u5e74\u306e\u53ce\u76ca\u306e44.12%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u9759\u8108\u5185\u6295\u4e0e\u306e\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u30b7\u30a7\u30a2\u306f\u3001\u9ac4\u8154\u5185\u3001\u76ae\u4e0b\u3001\u304a\u3088\u3073\u57cb\u3081\u8fbc\u307f\u578b\u30b7\u30b9\u30c6\u30e0\u304c2030\u5e74\u307e\u3067\u306b8.56%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u306b\u3064\u308c\u3066\u3001\u5f90\u3005\u306b\u6e1b\u5c11\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5206\u6790<\/p>\n<p>*   \u5317\u7c73: 2024\u5e74\u306b\u306f\u4e16\u754c\u306e\u58f2\u4e0a\u9ad8\u306e42.23%\u3092\u5360\u3081\u3001\u5c02\u9580\u30af\u30ea\u30cb\u30c3\u30af\u3001\u7d71\u5408\u3055\u308c\u305f\u652f\u6255\u8005\u30b7\u30b9\u30c6\u30e0\u3001FDA\u306e\u30aa\u30fc\u30d5\u30a1\u30f3\u30d5\u30ec\u30f3\u30c9\u30ea\u30fc\u306a\u59ff\u52e2\u306b\u652f\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u8fc5\u901f\u306a\u898f\u5236\u627f\u8a8d\u304c\u65e9\u671f\u306e\u511f\u9084\u3068\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u63a1\u7528\u3092\u4fc3\u9032\u3059\u308b\u300c\u4e57\u6570\u52b9\u679c\u300d\u304c\u3001\u305d\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u78ba\u7acb\u3059\u308b\u5faa\u74b0\u7684\u306a\u512a\u4f4d\u6027\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6b27\u5dde: \u4e2d\u592e\u96c6\u6a29\u7684\u306aEMA\u627f\u8a8d\u7d4c\u8def\u3092\u6301\u3064\u3082\u306e\u306e\u3001\u511f\u9084\u5236\u5ea6\u304c\u65ad\u7247\u5316\u3057\u3066\u3044\u308b\u305f\u3081\u30012\u756a\u76ee\u306b\u5927\u304d\u306a\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u306b\u304a\u3051\u308b\u533b\u7642\u6280\u8853\u8a55\u4fa1\u306f\u3001\u9ad8\u984d\u306a\u6cbb\u7642\u6cd5\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\u3092\u53b3\u3057\u304f\u5be9\u67fb\u3057\u3001\u5e02\u5834\u3078\u306e\u5b8c\u5168\u306a\u53c2\u5165\u3092\u9045\u3089\u305b\u308b\u30ea\u30b9\u30af\u30b7\u30a7\u30a2\u5951\u7d04\u3092\u8ab2\u3059\u3053\u3068\u3082\u3042\u308a\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: 9.72%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3057\u3066\u304a\u308a\u3001\u65e5\u672c\u306eSAKIGAKE\u3001\u4e2d\u56fd\u306e\u753b\u671f\u7684\u306a\u6cbb\u7642\u6cd5\u6307\u5b9a\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u8fc5\u901f\u5316\u30b9\u30ad\u30fc\u30e0\u306e\u6069\u6075\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u5404\u56fd\u306e\u5e0c\u5c11\u75be\u60a3\u30ea\u30b9\u30c8\u306f\u65e9\u671f\u30a2\u30af\u30bb\u30b9\u8cc7\u91d1\u3092\u89e3\u653e\u3057\u3001\u9ad8\u3044\u4eba\u53e3\u5bc6\u5ea6\u306f\u6709\u75c5\u7387\u304c\u4f4e\u3044\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u7d76\u5bfe\u7684\u306a\u60a3\u8005\u6570\u3092\u5897\u52a0\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<\/p>\n<p>\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u65ad\u7247\u5316\u3092\u793a\u3057\u3066\u304a\u308a\u3001\u4e0a\u4f4d5\u793e\u304c\u53ce\u76ca\u30b7\u30a7\u30a2\u306e\u7d04\u534a\u5206\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002AbbVie\u306b\u3088\u308bCerevel Therapeutics\u306e87\u5104\u7c73\u30c9\u30eb\u3067\u306e\u8cb7\u53ce\u3084\u3001Johnson &#038; Johnson\u306b\u3088\u308bIntra-Cellular Therapies\u306e146\u5104\u7c73\u30c9\u30eb\u3067\u306e\u8cb7\u53ce\u306f\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u30d5\u30e9\u30f3\u30c1\u30e3\u30a4\u30ba\u3068\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u6280\u8853\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306e\u9632\u885b\u7684\u306a\u52d5\u304d\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u6226\u7565\u7684\u306a\u5dee\u5225\u5316\u306f\u3001\u30c7\u30ea\u30d0\u30ea\u30fc\u3068\u30a2\u30af\u30bb\u30b9\u7269\u6d41\u306b\u307e\u3059\u307e\u3059\u4f9d\u5b58\u3057\u3066\u3044\u307e\u3059\u3002\u4f01\u696d\u306f\u3001RNA\u6cbb\u7642\u85ac\u306e\u8907\u6570\u65e5\u8f38\u9001\u306b\u304a\u3051\u308b\u6e29\u5ea6\u5b8c\u5168\u6027\u3092\u691c\u8a3c\u3059\u308b\u7279\u6ce8\u306e\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u6d41\u901a\u306b\u8cc7\u672c\u3092\u6295\u5165\u3057\u3066\u3044\u307e\u3059\u3002\u30b2\u30ce\u30e0\u30ab\u30a6\u30f3\u30bb\u30ea\u30f3\u30b0\u3001\u65c5\u884c\u8cbb\u511f\u9084\u3001\u4fa1\u5024\u30d9\u30fc\u30b9\u306e\u652f\u6255\u3044\u69cb\u9020\u3092\u63d0\u4f9b\u3059\u308b\u60a3\u8005\u30b5\u30dd\u30fc\u30c8\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u7af6\u4e89\u4e0a\u4e0d\u53ef\u6b20\u306a\u3082\u306e\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u4f01\u696d<\/p>\n<p>*   CSL Ltd<br \/>\n*   Merz Pharma GmbH &#038; Co. KGaA<br \/>\n*   Kedrion Biopharma Inc.<br \/>\n*   US WorldMeds LLC (Solstice Neurosciences LLC)<br \/>\n*   Aquestive Therapeutics Inc.<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2025\u5e742\u6708: Biogen\u3068Stoke Therapeutics\u304c\u30c9\u30e9\u30d9\u75c7\u5019\u7fa4\u306e\u30a2\u30f3\u30c1\u30bb\u30f3\u30b9\u5019\u88dc\u306b\u95a2\u3059\u308b\u5171\u540c\u7814\u7a76\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e7410\u6708: Bright Minds Biosciences\u3068Firefly Neuroscience\u304c\u3001BMB-101\u306eEEG\u30d9\u30fc\u30b9\u306e\u6b20\u795e\u3066\u3093\u304b\u3093\u306b\u95a2\u3059\u308b\u7b2cII\u76f8\u8a66\u9a13\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3044\u305f\u3057\u307e\u3059\u3002\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\uff08RNDs\uff09\u306f\u3001\u6709\u75c5\u7387\u304c1\u4e07\u4eba\u3042\u305f\u308a5\u4eba\u672a\u6e80\u3068\u5b9a\u7fa9\u3055\u308c\u3001\u8a3a\u65ad\u304c\u4e0d\u5341\u5206\u3067\u3042\u308a\u3001\u52b9\u679c\u7684\u306a\u6cbb\u7642\u6cd5\u304c\u4e0d\u8db3\u3057\u3066\u3044\u308b\u73fe\u72b6\u304c\u3042\u308a\u307e\u3059\u3002\u672c\u5831\u544a\u66f8\u306f\u3001\u5e02\u5834\u306e\u5b9a\u7fa9\u3001\u8abf\u67fb\u7bc4\u56f2\u3001\u8abf\u67fb\u65b9\u6cd5\u3001\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc\u3001\u5e02\u5834\u306e\u72b6\u6cc1\u3001\u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\u3001\u7af6\u4e89\u74b0\u5883\u3001\u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b\u3068\u3044\u3063\u305f\u4e3b\u8981\u306a\u30bb\u7ae0\u3067\u69cb\u6210\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>1. \u5e02\u5834\u306e\u72b6\u6cc1 (Market Landscape)<br \/>\n\u5e02\u5834\u306e\u6982\u8981\u3067\u306f\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306e\u5168\u4f53\u50cf\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u4ee5\u4e0b\u306e\u70b9\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<br \/>\n*   FDA\u306e\u8fc5\u901f\u627f\u8a8d\u5236\u5ea6\u3084\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\uff08\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\uff09\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u304c\u3001\u7814\u7a76\u958b\u767a\u6295\u8cc7\u3092\u5f37\u529b\u306b\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u8a3a\u65ad\u6280\u8853\u306e\u5411\u4e0a\u306b\u3088\u308a\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u306e\u6709\u75c5\u7387\u304c\u5897\u52a0\u50be\u5411\u306b\u3042\u308a\u307e\u3059\u3002<br \/>\n*   \u907a\u4f1d\u5b50\u6cbb\u7642\u3084RNA\u6cbb\u7642\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\u304b\u3089\u306e\u8cc7\u91d1\u8abf\u9054\u304c\u6025\u5897\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\uff08SMA\uff09\u306a\u3069\u306e\u65b0\u751f\u5150\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30ed\u30b0\u30e9\u30e0\u304c\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   AI\u3092\u6d3b\u7528\u3057\u305f\u30c9\u30e9\u30c3\u30b0\u30ea\u30d1\u30fc\u30d1\u30b7\u30f3\u30b0\uff08\u65e2\u5b58\u85ac\u518d\u958b\u767a\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u3001\u4e2d\u67a2\u795e\u7d4c\u7cfb\uff08CNS\uff09\u306e\u5e0c\u5c11\u75be\u60a3\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u9069\u5fdc\u75c7\u306e\u7279\u5b9a\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u56fd\u5883\u3092\u8d8a\u3048\u305f\u60a3\u8005\u652f\u63f4\u56e3\u4f53\u304c\u3001\u30b3\u30f3\u30d1\u30c3\u30b7\u30e7\u30cd\u30fc\u30c8\u30e6\u30fc\u30b9\uff08\u4eba\u9053\u7684\u898b\u5730\u304b\u3089\u306e\u672a\u627f\u8a8d\u85ac\u4f7f\u7528\uff09\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002<br \/>\n*   \u751f\u7269\u5b66\u7684\u88fd\u5264\u3084\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u9ad8\u30b3\u30b9\u30c8\u304c\u3001\u6cbb\u7642\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\u3092\u5236\u9650\u3057\u3001\u60a3\u8005\u306e\u30a2\u30af\u30bb\u30b9\u3092\u56f0\u96e3\u306b\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u60a3\u8005\u6570\u304c\u975e\u5e38\u306b\u5c11\u306a\u3044\u305f\u3081\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u88ab\u9a13\u8005\u52df\u96c6\u304c\u5927\u304d\u306a\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u4e2d\u67a2\u795e\u7d4c\u7cfb\uff08CNS\uff09\u306b\u5bfe\u3059\u308b\u53b3\u683c\u306a\u5b89\u5168\u6027\u8981\u4ef6\u304c\u3001\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u671f\u9593\u3092\u9577\u671f\u5316\u3055\u305b\u308b\u50be\u5411\u306b\u3042\u308a\u307e\u3059\u3002<br \/>\n*   \u65b0\u8208\u5e02\u5834\u306b\u304a\u3044\u3066\u306f\u3001\u9ac4\u8154\u5185RNA\u533b\u85ac\u54c1\u306e\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u7269\u6d41\u306b\u8ab2\u984c\u304c\u898b\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u4ed6\u3001\u30d0\u30ea\u30e5\u30fc\/\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u5206\u6790\u3001\u898f\u5236\u74b0\u5883\u3001\u6280\u8853\u7684\u5c55\u671b\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\uff08\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u4ea4\u6e09\u529b\u3001\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u7a0b\u5ea6\uff09\u3068\u3044\u3063\u305f\u591a\u89d2\u7684\u306a\u8996\u70b9\u304b\u3089\u5e02\u5834\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c (Market Size &#038; Growth Forecasts)<br \/>\n\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306f\u30012025\u5e74\u306e\u57fa\u6e96\u5e74\u304b\u30892030\u5e74\u307e\u3067\u306b7.20%\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u3067\u6210\u9577\u3057\u30012030\u5e74\u306b\u306f3\u51042523\u4e07\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306f\u4ee5\u4e0b\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u4fa1\u5024\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225: \u5c0f\u5206\u5b50\u533b\u85ac\u54c1\u3001\u751f\u7269\u5b66\u7684\u88fd\u5264\u304a\u3088\u3073\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u3001\u9175\u7d20\u88dc\u5145\u7642\u6cd5\u3001RNA\u30d9\u30fc\u30b9\u6cbb\u7642\u3001\u305d\u306e\u4ed6\u3002<br \/>\n*   \u9069\u5fdc\u75c7\u5225: \u810a\u9ac4\u6027\u7b4b\u840e\u7e2e\u75c7\u3001\u30c7\u30e5\u30b7\u30a7\u30f3\u30cc\u578b\u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3001\u30d0\u30c3\u30c6\u30f3\u75c5\u3001\u7b4b\u840e\u7e2e\u6027\u5074\u7d22\u786c\u5316\u75c7\uff08\u5e0c\u5c11\u578b\uff09\u3001\u30cf\u30f3\u30c1\u30f3\u30c8\u30f3\u75c5\u3001\u5e0c\u5c11\u3066\u3093\u304b\u3093\u75c7\u5019\u7fa4\u3001\u305d\u306e\u4ed6\u3002<br \/>\n*   \u6295\u4e0e\u7d4c\u8def\u5225: \u7d4c\u53e3\u3001\u9759\u8108\u5185\u3001\u305d\u306e\u4ed6\u3002<br \/>\n*   \u5730\u57df\u5225: \u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u305d\u306e\u4ed6\u6b27\u5dde\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u30a4\u30f3\u30c9\u3001\u65e5\u672c\u3001\u97d3\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u305d\u306e\u4ed6\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u3001\u305d\u306e\u4ed6\u5357\u7c73\uff09\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\uff08GCC\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u3001\u305d\u306e\u4ed6\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\uff09\u3002\u3053\u308c\u3089\u306e\u4e3b\u8981\u5730\u57df\u306b\u304a\u3051\u308b17\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u8a73\u7d30\u306b\u30ab\u30d0\u30fc\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>3. \u7af6\u4e89\u74b0\u5883 (Competitive Landscape)<br \/>\n\u7af6\u4e89\u74b0\u5883\u306e\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001\u5e02\u5834\u96c6\u4e2d\u5ea6\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u3001\u304a\u3088\u3073\u4e3b\u8981\u4f01\u696d\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Biogen Inc.\u3001Roche Holding AG\u3001Novartis AG\u3001Pfizer Inc.\u3001Sarepta Therapeutics, Inc.\u3001Ionis Pharmaceuticals, Inc.\u3001UCB S.A.\u3001Argenx SE\u3001Reata Pharmaceuticals, Inc.\u3001Sanofi S.A.\u3001AstraZeneca PLC\u3001BioMarin Pharmaceutical Inc.\u3001Jazz Pharmaceuticals plc\u3001Ultragenyx Pharmaceutical Inc.\u3001PTC Therapeutics, Inc.\u3001CSL Limited\u3001Ipsen S.A.\u3001Mitsubishi Tanabe Pharma Corp.\u3001Marinus Pharmaceuticals, Inc.\u3001Catalyst Pharmaceuticals, Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5404\u4f01\u696d\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u304a\u3088\u3073\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u8ca1\u52d9\u60c5\u5831\uff08\u5165\u624b\u53ef\u80fd\u306a\u5834\u5408\uff09\u3001\u6226\u7565\u7684\u60c5\u5831\u3001\u5e02\u5834\u30e9\u30f3\u30af\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1\u304a\u3088\u3073\u30b5\u30fc\u30d3\u30b9\u3001\u6700\u8fd1\u306e\u52d5\u5411\u306a\u3069\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>4. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b (Market Opportunities &#038; Future Outlook)<br \/>\n\u672c\u30bb\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001\u672a\u958b\u62d3\u5206\u91ce\uff08\u30db\u30ef\u30a4\u30c8\u30b9\u30da\u30fc\u30b9\uff09\u3068\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u8a55\u4fa1\u3092\u901a\u3058\u3066\u3001\u5e02\u5834\u306e\u5c06\u6765\u7684\u306a\u6210\u9577\u6a5f\u4f1a\u304c\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>5. \u30ec\u30dd\u30fc\u30c8\u3067\u56de\u7b54\u3055\u308c\u308b\u4e3b\u8981\u306a\u8cea\u554f<br \/>\n\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306a\u4e3b\u8981\u306a\u8cea\u554f\u306b\u5bfe\u3059\u308b\u56de\u7b54\u304c\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306e\u73fe\u5728\u306e\u898f\u6a21\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<br \/>\n    *   2030\u5e74\u307e\u3067\u306b3\u51042523\u4e07\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u30012025\u5e74\u306e\u57fa\u6e96\u5e74\u304b\u30897.20%\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u3092\u53cd\u6620\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u6700\u3082\u901f\u3044\u624b\u7d9a\u304d\u7684\u6210\u9577\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u308b\u5730\u57df\u306f\u3069\u3053\u3067\u3059\u304b\uff1f<br \/>\n    *   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u9ad8\u3044\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u5e0c\u5c11\u795e\u7d4c\u75be\u60a3\u6cbb\u7642\u5e02\u5834\u306e\u73fe\u72b6\u3068\u5c06\u6765\u306e\u5c55\u671b\u3092\u7406\u89e3\u3059\u308b\u305f\u3081\u306e\u8cb4\u91cd\u306a\u60c5\u5831\u6e90\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79713"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=79713"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79713\/revisions"}],"predecessor-version":[{"id":79716,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/79713\/revisions\/79716"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=79713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=79713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=79713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}